Abstract:Background Gene therapy using a recombinant adenovirus (Ad) encoding secretory human endostatin (Ad-Endo) has been demonstrated to be a promising antiangiogenesis and antitumor strategy of in animal models and clinical trials. The E1B55KD-deficient Ad dl 1520 was also found to replicate selectively in and destroy cancer cells. In this study, we aimed to investigate the antitumor effects of antiangiogenic agent Ad-Endo combined with the oncolytic Ad dl 1520 on gastric cancer (GC) in vitro and in vivo and determine the mechanisms of these effects. Methods The Ad DNA copy number was determined by real-time PCR, and gene expression was assessed by ELISA, Western blotting or immunohistochemistry. The anti-proliferation effect (cytotoxicity) of Ad was assessed using the colorimetry-based MTT cell viability assay. The antitumor effects were evaluated in BALB/c nude mice carrying SGC-7901 GC xenografts. The microvessel density and Ad replication in tumor tissue were evaluated by checking the expression of CD34 and hexon proteins, respectively. Results dl 1520 replicated selectively in GC cells harboring an abnormal p53 pathway, including p53 mutation and the loss of p14 ARF expression, but did not in normal epithelial cells. In cultured GC cells, dl 1520 rescued Ad-Endo replication, and dramatically promoted endostatin expression by Ad-Endo in a dose- and time-dependent manner. In turn, the addition of Ad-Endo enhanced the inhibitory effect of dl 1520 on the proliferation of GC cells. The transgenic expression of Ad5 E1A and E1B19K simulated the rescue effect of dl 1520 supporting Ad-Endo replication in GC cells. In the nude mouse xenograft model, the combined treatment with dl 1520 and Ad-Endo significantly inhibited tumor angiogenesis and the growth of GC xenografts through the increased endostatin expression and oncolytic effects. Conclusions Ad-Endo combined with dl 1520 has more antitumor efficacy against GC than Ad-Endo or dl 1520 alone. These findings indicate that the combination of Ad-mediated antiangiogenic gene therapy and oncolytic Ad therapeutics could be one of promising comprehensive treatment strategies for GC.

Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models.

Suppression of Ovarian Cancer Growth Via Systemic Administration with Liposome-Encapsulated Adenovirus-Encoding Endostatin

Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus

Endostatin Gene Therapy for Liver Cancer by a Recombinant Adenovirus Delivery

Inhibition of Angiogenesis and the Growth of Murine Colon Cancer with Recombinant Human Endostatin Adenovirus

Adenovirus-Mediated Combined Anti-Angiogenic and Pro-Apoptotic Gene Therapy Enhances Antitumor Efficacy in Hepatocellular Carcinoma

Inhibition of Tumor Growth in Xenografted Nude Mice with Adenovirus-Mediated Endostatin Gene Comparison with Recombinant Endostatin Protein.

Inhibition of Tumor Growth and Metastasis Via Local Administration of Recombinant Human Endostatin Adenovirus

Antitumor Efficacy of a Recombinant Adenovirus Encoding Endostatin Combined with an E1B55KD-deficient Adenovirus in Gastric Cancer Cells

Effective Gene-Viral Therapy For Telomerase-Positive Cancers By Selective Replicative-Competent Adenovirus Combining With Endostatin Gene

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Antiangiogenesis Gene Armed Tumor‐targeting Adenovirus Yields Multiple Antitumor Activities in Human HCC Xenografts in Nude Mice

Menstrual Blood-Derived Stem Cells As Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer

Inhibitory Effect of Gastric Cancer by Adenoviral Transduction of Mouse Endostatin Gene

Adenovirus‐mediated Intra‐tumoral Delivery of the Human Endostatin Gene Inhibits Tumor Growth in Nasopharyngeal Carcinoma

Pharmacokinetic and Pharmacodynamic Study of Intratumoral Injection of an Adenovirus Encoding Endostatin in Patients with Advanced Tumors

[Antitumor Effect by Combination of Recombinant Endostatin Adenovirus with Carboplatin].

Synergistic Anti-Tumor Effect of Recombinant Human Endostatin Adenovirus Combined with Gemcitabine

Treatment of Pancreatic Carcinoma by Adenoviral Mediated Gene Transfer of Vasostatin in Mice

Suppressive Effect of Recombinant Adenovirus-mediated Endostatin Gene by Intraperitoneal Injection on Pancreatic Cancer in an Orthotropic Nude Mouse Model

Suppression of Lung Cancer in Murine Model: Treated by Combination of Recombinant Human Endostsatin Adenovirus with Low-Dose Cisplatin